BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chapman BC, Paniccia A, Hosokawa PW, Henderson WG, Overbey DM, Messersmith W, McCarter MD, Gleisner A, Edil BH, Schulick RD, Gajdos C. Impact of Facility Type and Surgical Volume on 10-Year Survival in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma. J Am Coll Surg 2017;224:362-72. [PMID: 27923615 DOI: 10.1016/j.jamcollsurg.2016.11.011] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhao B, Lu Y, Cao X, Zhu W, Kong L, Ji H, Zhang F, Lin X, Guan Q, Ou K, Zhang X, Chen Q. MiRNA-124 inhibits the proliferation, migration and invasion of cancer cell in hepatocellular carcinoma by downregulating lncRNA-UCA1. Onco Targets Ther 2019;12:4509-16. [PMID: 31354286 DOI: 10.2147/OTT.S205169] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
2 Lee GC, Gamblin TC, Fong ZV, Ferrone CR, Goyal L, Lillemoe KD, Blaszkowsky LS, Tanabe KK, Qadan M. Facility Type is Associated with Margin Status and Overall Survival of Patients with Resected Intrahepatic Cholangiocarcinoma. Ann Surg Oncol 2019;26:4091-9. [PMID: 31368018 DOI: 10.1245/s10434-019-07657-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
3 Neuwirth MG, Bierema C, Sinnamon AJ, Fraker DL, Kelz RR, Roses RE, Karakousis GC. Trends in major upper abdominal surgery for cancer in octogenarians: Has there been a change in patient selection?: Major Cancer Surgery in Octogenarians. Cancer 2018;124:125-35. [DOI: 10.1002/cncr.30977] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
4 Li Z, Xue T, Yang C, Wang Y, Zhu X, Ni C. EGFL7 promotes hepatocellular carcinoma cell proliferation and inhibits cell apoptosis through increasing CKS2 expression by activating Wnt/β‐catenin signaling. J Cell Biochem 2018;119:10327-37. [DOI: 10.1002/jcb.27375] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
5 Beane JD, Hyer M, Mehta R, Onuma AE, Gleeson EM, Thompson VM, Pawlik TM, Pitt HA. Optimal hepatic surgery: Are we making progress in North America? Surgery 2021:S0039-6060(21)00636-X. [PMID: 34325906 DOI: 10.1016/j.surg.2021.06.028] [Reference Citation Analysis]
6 Hauser A, Dutta SW, Showalter TN, Sheehan JP, Grover S, Trifiletti DM. Impact of academic facility type and volume on post-surgical outcomes following diagnosis of glioblastoma. J Clin Neurosci 2018;47:103-10. [PMID: 29113851 DOI: 10.1016/j.jocn.2017.10.087] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
7 Zhao H, Xie Z, Tang G, Wei S, Chen G. Knockdown of terminal differentiation induced ncRNA (TINCR) suppresses proliferation and invasion in hepatocellular carcinoma by targeting the miR-218-5p/DEAD-box helicase 5 (DDX5) axis. J Cell Physiol 2020;235:6990-7002. [PMID: 31994189 DOI: 10.1002/jcp.29595] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
8 Franchi E, Donadon M, Torzilli G. Effects of volume on outcome in hepatobiliary surgery: a review with guidelines proposal. Glob Health Med 2020;2:292-7. [PMID: 33330823 DOI: 10.35772/ghm.2020.01013] [Reference Citation Analysis]
9 Sempokuya T, Wong LL. Ten-year survival and recurrence of hepatocellular cancer. Hepatoma Res 2019;5:38. [PMID: 31701016 DOI: 10.20517/2394-5079.2019.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
10 Uppal A, Smieliauskas F, Sharma MR, Maron SB, Polite BN, Posner MC, Turaga K. Facilities that service economically advantaged neighborhoods perform surgical metastasectomy more often for patients with colorectal liver metastases. Cancer 2020;126:281-92. [PMID: 31639217 DOI: 10.1002/cncr.32529] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
11 Liaw CW, Winoker JS, Wiklund P, Sfakianos J, Galsky MD, Mehrazin R. The clinical and economic burden of perioperative complications of radical cystectomy. Transl Androl Urol 2019;8:S277-9. [PMID: 31392144 DOI: 10.21037/tau.2019.03.04] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Boffa DJ, Mallin K, Herrin J, Resio B, Salazar MC, Palis B, Facktor M, McCabe R, Nelson H, Shulman LN. Survival After Cancer Treatment at Top-Ranked US Cancer Hospitals vs Affiliates of Top-Ranked Cancer Hospitals. JAMA Netw Open 2020;3:e203942. [PMID: 32453382 DOI: 10.1001/jamanetworkopen.2020.3942] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Uhlig J, Sellers CM, Khan SA, Cha C, Kim HS. Hepatocellular carcinoma: Impact of academic setting and hospital volume on patient survival. Surg Oncol 2019;31:111-8. [PMID: 31654956 DOI: 10.1016/j.suronc.2019.10.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kamarajah SK, Nathan H. Strengths and Limitations of Registries in Surgical Oncology Research. J Gastrointest Surg 2021. [PMID: 34506025 DOI: 10.1007/s11605-021-05094-y] [Reference Citation Analysis]
15 Nogueira LM, Yabroff KR, Bernstein A. Climate change and cancer. CA Cancer J Clin 2020;70:239-44. [PMID: 32420634 DOI: 10.3322/caac.21610] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
16 Beal EW, Mehta R, Merath K, Tsilimigras DI, Hyer JM, Paredes A, Dillhoff ME, Cloyd J, Ejaz A, Pawlik TM. Outcomes After Resection of Hepatocellular Carcinoma: Intersection of Travel Distance and Hospital Volume. J Gastrointest Surg 2019;23:1425-34. [DOI: 10.1007/s11605-019-04233-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
17 Banerjee S, Zhao B, Sicklick JK, Aslam S, Burgoyne AM, Kelly KJ. Commission on Cancer Facility Type is Associated with Overall Survival in Patients with Gastric Adenocarcinoma in the United States. Ann Surg Oncol 2021;28:2846-55. [PMID: 33389292 DOI: 10.1245/s10434-020-09422-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Cotton RT, Tran Cao HS, Rana AA, Sada YH, Axelrod DA, Goss JA, Wilson MA, Curley SA, Massarweh NN. Impact of the Treating Hospital on Care Outcomes for Hepatocellular Carcinoma. Hepatology 2018;68:1879-89. [PMID: 30070392 DOI: 10.1002/hep.30128] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
19 Shrime MG, Iverson KR, Yorlets R, Roder-DeWan S, Gage AD, Leslie H, Malata A. Predicted effect of regionalised delivery care on neonatal mortality, utilisation, financial risk, and patient utility in Malawi: an agent-based modelling analysis. Lancet Glob Health 2019;7:e932-9. [PMID: 31200892 DOI: 10.1016/S2214-109X(19)30170-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
20 Opneja A, Cioffi G, Alahmadi A, Jones N, Tang TY, Patil N, Bajor DL, Saltzman JN, Mohamed A, Selfridge E, Mangla A, Barnholtz-Sloan J, Lee RT. Adoption of single agent anticancer therapy for advanced hepatocellular carcinoma and impact of facility type, insurance status, and income on survival: Analysis of the national cancer database 2004-2014. Cancer Med 2021;10:4397-404. [PMID: 34060249 DOI: 10.1002/cam4.3985] [Reference Citation Analysis]
21 Wu G, Li Z, Wang Y, Ju X, Huang R. miR-34a Inhibits Cell Proliferation by Targeting SATB2 in Hepatocellular Carcinoma. Biomed Res Int. 2018;2018:2863902. [PMID: 30627547 DOI: 10.1155/2018/2863902] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
22 Platoff RM, Lou J, Bush K, Zhu C, Spitz E, Gaughan JP, Atabek U, Spitz F, Hong YK. Gastric Neuroendocrine Tumor Treatment and Survival Outcome Depends on Facility Type. Am Surg 2022;:31348221109460. [PMID: 35722860 DOI: 10.1177/00031348221109460] [Reference Citation Analysis]
23 Siegel JB, Allen S, Engelhardt KE, Morgan KA, Lancaster WP. Travel distance and overall survival in hepatocellular cancer care. Am J Surg 2021;222:584-93. [PMID: 33413878 DOI: 10.1016/j.amjsurg.2020.12.052] [Reference Citation Analysis]
24 Lam A, Yoshida EJ, Bui K, Katrivesis J, Fernando D, Nelson K, Abi-jaoudeh N. Demographic and facility volume related outcomes in radiofrequency ablation for early-stage hepatocellular carcinoma. HPB 2019;21:849-56. [DOI: 10.1016/j.hpb.2018.10.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
25 Zhuang R, Zhang X, Lu D, Wang J, Zhuo J, Wei X, Ling Q, Xie H, Zheng S, Xu X. lncRNA DRHC inhibits proliferation and invasion in hepatocellular carcinoma via c-Myb-regulated MEK/ERK signaling. Mol Carcinog 2019;58:366-75. [PMID: 30362626 DOI: 10.1002/mc.22934] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
26 Matsuo K, Matsuzaki S, Mandelbaum RS, Matsushima K, Klar M, Grubbs BH, Roman LD, Wright JD. Association between hospital surgical volume and perioperative outcomes of fertility-sparing trachelectomy for cervical cancer: A national study in the United States. Gynecol Oncol 2020;157:173-80. [PMID: 31982179 DOI: 10.1016/j.ygyno.2020.01.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
27 Mahato D, De Biase G, Ruiz-garcia HJ, Grover S, Rosenfeld S, Quiñones-hinojosa A, Trifiletti DM. Impact of facility type and volume on post-surgical outcomes following diagnosis of WHO grade II glioma. Journal of Clinical Neuroscience 2018;58:34-41. [DOI: 10.1016/j.jocn.2018.10.078] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
28 Atallah C, Oduyale O, Stem M, Eltahir A, Almaazmi HH, Efron JE, Safar B. Are academic hospitals better at treating metastatic colorectal cancer? Surgery 2021;169:248-56. [PMID: 32680747 DOI: 10.1016/j.surg.2020.05.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
29 Zhang Z, Fang X, Xie G, Zhu J. GATA3 is downregulated in HCC and accelerates HCC aggressiveness by transcriptionally inhibiting slug expression. Oncol Lett 2021;21:231. [PMID: 33613720 DOI: 10.3892/ol.2021.12492] [Reference Citation Analysis]
30 Reinders MTM, van Meer S, Burgmans MC, de Jong KP, Klümpen HJ, de Man RA, Ramsoekh DS, Sprengers D, Tjwa ETTL, de Vos-Geelen J, van Erpecum KJ, van der Geest LGM; Dutch Hepatocellular & Cholangiocarcinoma Group (DHCG). Trends in incidence, diagnosis, treatment and survival of hepatocellular carcinoma in a low-incidence country: Data from the Netherlands in the period 2009-2016. Eur J Cancer 2020;137:214-23. [PMID: 32799035 DOI: 10.1016/j.ejca.2020.07.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
31 Lumpkin S, Stitzenberg K. Regionalization and Its Alternatives. Surg Oncol Clin N Am 2018;27:685-704. [PMID: 30213413 DOI: 10.1016/j.soc.2018.05.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
32 Wu L, Tsilimigras DI, Paredes AZ, Mehta R, Hyer JM, Merath K, Sahara K, Bagante F, Beal EW, Shen F, Pawlik TM. Trends in the Incidence, Treatment and Outcomes of Patients with Intrahepatic Cholangiocarcinoma in the USA: Facility Type is Associated with Margin Status, Use of Lymphadenectomy and Overall Survival. World J Surg. 2019;43:1777-1787. [PMID: 30820734 DOI: 10.1007/s00268-019-04966-4] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 13.3] [Reference Citation Analysis]
33 Sui W, Wallis CJD, Luckenbaugh AN, Barocas DA, Chang SS, Penson DF, Resnick MJ, Laviana AA. The Impact of Hospital Volume on Short-term and Long-term Outcomes for Patients Undergoing Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma. Urology 2021;147:135-42. [PMID: 32891638 DOI: 10.1016/j.urology.2020.07.062] [Reference Citation Analysis]
34 Hue JJ, Sugumar K, Markt SC, Hardacre JM, Ammori JB, Rothermel LD, Winter JM, Ocuin LM. Facility volume-survival relationship in patients with early-stage pancreatic adenocarcinoma treated with neoadjuvant chemotherapy followed by pancreatoduodenectomy. Surgery 2021;170:207-14. [PMID: 33454134 DOI: 10.1016/j.surg.2020.12.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
35 Tchelebi LT, Shen B, Wang M, Gusani NJ, Walter V, Abrams R, Verma V, Zaorsky NG. Impact of radiation therapy facility volume on survival in patients with cancer. Cancer 2021. [PMID: 34398470 DOI: 10.1002/cncr.33777] [Reference Citation Analysis]
36 Schwarz C, Fitschek F, Mittlböck M, Saukel V, Bota S, Ferlitsch M, Ferlitsch A, Bodingbauer M, Kaczirek K. von Willebrand Factor Antigen Predicts Outcomes in Patients after Liver Resection of Hepatocellular Carcinoma. Gut Liver 2020;14:218-24. [PMID: 30428508 DOI: 10.5009/gnl17115] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
37 Zhu P, Du XL, Zhu JJ, Esquenazi Y. Improved survival of glioblastoma patients treated at academic and high-volume facilities: a hospital-based study from the National Cancer Database. J Neurosurg 2019;132:491-502. [PMID: 30771780 DOI: 10.3171/2018.10.JNS182247] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
38 Abarca T, Gao Y, Monga V, Tanas MR, Milhem MM, Miller BJ. Improved survival for extremity soft tissue sarcoma treated in high-volume facilities. J Surg Oncol 2018;117:1479-86. [PMID: 29633281 DOI: 10.1002/jso.25052] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
39 Luo Q, Yang D, Qi Q, Huang C, Chen B, Liu W, Shi L, Xia Y, Tang L, Fang J, Ou Y, Geng Y, Chen Z. Role of the Death Receptor and Endoplasmic Reticulum Stress Signaling Pathways in Polyphyllin I-Regulated Apoptosis of Human Hepatocellular Carcinoma HepG2 Cells. Biomed Res Int 2018;2018:5241941. [PMID: 30671458 DOI: 10.1155/2018/5241941] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
40 Deng B, Yang M, Wang M, Liu Z. Development and validation of 9-long Non-coding RNA signature to predicting survival in hepatocellular carcinoma. Medicine (Baltimore) 2020;99:e20422. [PMID: 32481346 DOI: 10.1097/MD.0000000000020422] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
41 Freeman JL, DeMonte F, Al-Holou W, Gidley PW, Hanna EY, Kupferman ME, Su SY, Raza SM. Impact of early access to multidisciplinary care on treatment outcomes in patients with skull base chordoma. Acta Neurochir (Wien) 2018;160:731-40. [PMID: 29270681 DOI: 10.1007/s00701-017-3409-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
42 Chang YS, Lee YT, Yen JC, Chang YC, Lin LL, Chan WL, Chang WC, Lin SY, Chang JG. Long Noncoding RNA NTT Context-Dependently Regulates MYB by Interacting With Activated Complex in Hepatocellular Carcinoma Cells. Front Oncol 2021;11:592045. [PMID: 34616668 DOI: 10.3389/fonc.2021.592045] [Reference Citation Analysis]